-
Hoth Therapeutics Leverages OpenClaw™ AI Platform to Advance Drug Discovery
NASDAQ: $HOTH Hoth Therapeutics Deploys OpenClaw™ AI Platform to Accelerate Drug Discovery Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, has announced a significant strategic advancement with the deployment of OpenClaw™, its new, advanced AI-enabled computational platform. This move signifies a major commitment to integrating artificial intelligence into the core of its drug discovery and development…
-
Hoth Therapeutics Leverages OpenAI API to Accelerate Development of Orphan Oncology Program, HT-KIT
NASDAQ: $HOTH Hoth Therapeutics, Inc., a biopharmaceutical company dedicated to patient-focused therapies, recently announced a significant strategic move: the deployment of the OpenAI API to bolster the development of its orphan-designated therapy, HT-KIT. This innovative integration targets rare and aggressive KIT-driven cancers, marking a forward-thinking approach to drug development within the oncology space. AI Integration…
-
Hoth Therapeutics Reports Significant Initial Results in Novel Cancer Therapy Trial
NASDAQ: $HOTH A recent press release from PR Newswire highlights exciting early data from Hoth Therapeutics regarding their ongoing clinical study involving a novel treatment approach for cancer patients whose tumors express the Epidermal Growth Factor Receptor (EGFR). The announcement, specifically concerning the open-label pharmacokinetic (PK) cohort of the study, signals a promising step forward…